Hans‐Peter Hartung

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

W. I. McDonald, Alistair Compston, Gilles Edan et al. · Annals of Neurology · 2001 · 7K citations

Medicine, Internal Medicine, Neurology +10

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2010 · 2.2K citations · Full text

Life Sciences, Immunology, Neurology +15

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Life Sciences, Immunology, Neurology +17

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text

Life Sciences, Immunology, Neurology +17

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

Hans‐Peter Hartung, R Gonsette, Nikolaus König et al. · The Lancet · 2002 · 945 citations

Life Sciences, Neurology, Pharmacology +9